Fig. 5

Comprehensive analysis of immune-related indicators and prognostic characteristics in high- risk and Low - risk Groups. (a) Proportion of immune cells in high-risk group and low-risk group; (b) Screening of differential immune cells between high-risk and low-risk groups; (c) Correlation analysis of prognostic genes and differential immune cells (e) Expression level of immune checkpoint genes; (f) Distribution of immunomodulators in the high-risk and low-risk groups of the training set.